← Human Trials & Peer-Reviewed Studies
Effects of nicotine and alcohol on affective responses to emotionally toned film clips.
Plain-language guide to PMID 21327759 (2011): randomized controlled trial of Therapeutic nicotine (patch, non-peptide) in 2, participants.
Key Facts
- PMID
- 21327759
- Journal
- Psychopharmacology
- Year
- 2011
- Study type
- Randomized Controlled Trial
- Authors
- Dawkins L et al. (2 authors)
- DOI
- 10.1007/s00213-011-2197-4
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Therapeutic nicotine (patch, non-peptide), published as a randomized controlled trial.
In both studies, 'sadness' responses to negatively valenced clips were also included.
Who Took Part
According to the abstract, 2, participants were involved.
The age groups tagged for this paper are teenagers, young adults and adults, both men and women.
Participants then rated the extent to which they felt a list of emotions in response to each of 16 film clips.
In Study 2, participants were additionally allocated to an alcohol manipulation in which they received either alcohol or placebo.
How the Study Was Run
The design is described as randomized and placebo-controlled.
Because people in this Therapeutic nicotine (patch, non-peptide) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
The comparison arm used a placebo, so changes seen with Therapeutic nicotine (patch, non-peptide) could be set against what happens without it.
Thirty-two and 77 smokers, respectively, in Studies 1 and 2 were randomly allocated to abstain from smoking for 10 h (abstinent smokers) or smoke as usual (satiated smokers).
What Was Measured
Topics PubMed links to this paper include Affect, Dopamine, Emotions, Ethanol, Happiness, Motion Pictures and Nicotine.
What This Means in Plain Language
The paper is a randomized and placebo-controlled study of Therapeutic nicotine (patch, non-peptide) in 2, participants.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
Results are reported in around 5 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2011 (Psychopharmacology), a journal based in Germany.
More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.
Our Notes on the Compound
Therapeutic nicotine (patch, non-peptide): Pure nicotine as a signaling tool, separated from smoking and vaping.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.